| Recordati AG - Eligard 22.5 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension |
| 56892 | | 01 | | Eligard 22.5 mg | | Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | | L02AE02 | | Leuprorelin | | 29.12.2004 | | |
|
| Composition |
| Praeparatio cryodesiccata: leuprorelini acetas 22.5 mg, pro vitro.
Solvens: poly(lactidum-co-glycolidum) 75/25, N-methylpyrrolidonum, pro vitro. |
| Packungsbestandteile |
| Solvens | | | Injection preparation | | | | | | | | | BAG: Active Agent | Dose |
|---|
| Leuproreline Acetate | 22.5 mg |
| | | | Inactive agents |
|---|
| N-Methylpyrrolidonum | | Poly(Lactidum-Co-Glycolidum) |
| |
| Praeparatio cryodesiccata: | | | Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | | | | | | | | Active Agent | Dose |
|---|
| Leuproreline Acetate | 22.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Leuproreline Acetate | 22.5 mg |
|
| Solvens | | | Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension | | | | | | | | | BAG: Active Agent | Dose |
|---|
| Leuproreline Acetate | 22.5 mg |
| | | | Inactive agents | Dose |
|---|
| N-Methylpyrrolidonum | | | Poly(Lactidum-Co-Glycolidum) | 75 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 311.35 | 355.05 | A | SL | Yes |
|
